Illumina INC ILLUMINA ORD SHS
Illumina INC ILLUMINA ORD SHS/ US4523271090 /
0J8Z
28/03/2024 00:00:00
|
Chg.
-
|
Volume |
Bid06:00:06 |
Demandez à06:00:06 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
137.57USD
|
-
|
777 Chiffrre d'affaires: - |
-Bid taille: - |
-Ask la taille: - |
19.66 Mrd.USD |
- |
- |
Description de l'entreprise
Illumina is improving human health by unlocking the power of the genome. The company's focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina's products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Conseil d'administration & Conseil de surveillance
PDG |
Charles Dadswell |
Conseil d'administration |
Ankur Dhingra, Steve Barnard, Nicole Berry, Aimee Hoyt, Kevin Pegels, Li Qing, Kathryne Reeves, Carissa Rollins, Salli Schwartz, Susan Tousi, Bas Verhoef, Gretchen Weightman |
Conseil de surveillance |
Stephen P. MacMillan, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Philip Schiller, Sue Siegel, Andrew Teno, Scott B. Ullem, Anna Richo |
Données de l'entreprise
Nom: |
Illumina Inc. |
Adresse: |
5200 Illumina Way,San Diego, California 92122, USA |
Téléphone: |
+1-858-202-4500 |
Fax: |
+1-858-202-4766 |
Courriel: |
info@illumina.com
|
Internet: |
www.illumina.com/ |
Industrie: |
Healthcare |
Secteur: |
Medical Products |
Sous-secteur: |
Advanced Medical Devices |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
48.29% |
IPO date: |
28/07/2000 |
Relations avec les investisseurs
Nom: |
- |
Téléphone IR: |
+1-858-291-6421 |
IR-Fax: |
- |
E-mail IR: |
ir@illumina.com
|
Calendrier de l'entreprise
CW 32 | 06/08/2024
Interim Report 2nd Quarter/6 Months
|
Principaux actionnaires
Autres |
|
56.21% |
Vanguard Group |
|
11.41% |
BlackRock Inc. |
|
8.35% |
EDGEWOOD MANAGEMENT LLC |
|
4.32% |
State Street Corporation |
|
4.22% |
BAILLIE GIFFORD CO |
|
3.31% |
LOOMIS SAYLES CO L P |
|
2.78% |
HENDERSON GROUP PLC |
|
2.76% |
Morgan Stanley |
|
2.32% |
Autres |
|
4.31% |